Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
Pertussis fimbriae 2 + 3; Pertussis toxoid; Pertactin; Diphtheria toxoid; Tetanus toxoid; Poliovirus; Pertussis filamentous haemagglutinin
Sanofi-Aventis Australia Pty Ltd
Medicine Registered
ADACEL ® POLIO _Pertussis Vaccine - Acellular and Diphtheria and Tetanus Toxoids (Adsorbed) Combined with Inactivated_ _Poliovirus Type 1, 2 and 3 (Vero cell)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ADACEL ® POLIO. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines, including vaccines, have risks and benefits. Your doctor has weighed the risks of you or your child having ADACEL ® POLIO against the benefits they expect it will have. IF YOU HAVE ANY CONCERNS ABOUT THIS VACCINE, ASK YOUR DOCTOR, NURSE OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT ADACEL ® POLIO IS USED FOR ADACEL ® POLIO is a vaccine used to help prevent whooping cough (pertussis), tetanus, diphtheria and polio. This vaccine is for use as a booster in adults, adolescents and children aged four years and older who have previously received childhood immunisation. Children from four to six years of age should have already received four doses of whooping cough, tetanus, diphtheria and polio vaccine. ADACEL ® POLIO is not intended for primary immunisation. The use of ADACEL ® POLIO should be determined on the basis of official recommendations and by your doctor. Polio, whooping cough, tetanus and diphtheria cause significant sickness and sometimes death in unvaccinated infants, children, and adults. _HOW IT WORKS_ ADACEL ® POLIO works by causing the body to produce its own protection against whooping cough, tetanus, diphtheria, and polio. It does this by making substances called antibodies in the blood, which fight the bacteria and toxins that cause these diseases. If a vaccinated person comes into contact with these bacteria and toxins, the body is usually ready to destroy them. It usually takes several weeks after vaccination to develop protection against these diseases. A course of whooping cough, tetanus, diphtheria and polio vaccine is usually Baca dokumen lengkap
ADACEL POLIO Product Information Page 1 of 14 AUSTRALIAN PRODUCT INFORMATION NAME OF THE DRUG ADACEL ® POLIO Pertussis Vaccine - Acellular and Diphtheria and Tetanus Toxoids (Adsorbed) Combined with Inactivated Poliovirus Type 1, 2 and 3 (Vero cell) DESCRIPTION ADACEL ® POLIO is a sterile, uniform cloudy, white suspension for injection in prefilled syringes or vials. Each 0.5 mL dose of ADACEL ® POLIO contains: 2.5 µg pertussis toxoid 5 µg pertussis filamentous haemagglutinin 5 µg pertussis fimbriae types 2 and 3 3 µg pertussis pertactin 2 IU (2 LfU) diphtheria toxoid 20 IU (5 LfU a ) tetanus toxoid 40 DagU poliovirus inactivated type 1, Vero (Mahoney) 8 DagU poliovirus inactivated type 2, Vero (MEF1) 32 DagU poliovirus inactivated type 3, Vero (Saukett) 1.5 mg aluminium phosphate (equivalent to 0.33 mg aluminium) 0.6% v/v phenoxyethanol 0.025 µg polymyxin B sulphate 0.02 µg neomycin 0.2 µg streptomycin 0.005 mg formaldehyde 0.02 mg glutaraldehyde 0.01% polysorbate 80 water for injections to 0.5 mL a The formulated content of 5LfU per 0.5 mL of tetanus toxoid is the same as in the related product Tripacel ® . The vaccine is prepared from: adsorbed purified and formaldehyde detoxified diphtheria and tetanus toxins; adsorbed purified and glutaraldehyde detoxified pertussis toxin (pertussis toxoid or PT); adsorbed purified and formaldehyde treated filamentous haemagglutinin (FHA); adsorbed purified pertactin (PRN) and fimbriae types 2 and 3 (FIM); and poliomyelitis viruses type 1, 2 and 3 cultivated on Vero cells, purified and then inactivated by formaldehyde. ADACEL POLIO Product Information Page 2 of 14 ADACEL ® POLIO is a diphtheria-tetanus-acellular pertussis combination vaccine (dTpa) combined with Baca dokumen lengkap